Epilepsy research
-
Multicenter Study Clinical Trial
A 21-week open-label clinical trial of pregabalin as adjunctive therapy in partial seizures at multiple centers in Mexico (PREPS Mexico).
To investigate the efficacy of pregabalin in the treatment of refractory partial seizures. ⋯ Pregabalin was well tolerated and associated with significant reductions in seizure frequency.